Zhaoke Ophthalmology’s IND Application for Potential First Myopia Drug to Market in China and Globally, NVK-002, Approved for Phase III Clinical Trial by the CDE

Adapalene Clindamycin Hydrochloride Combination Gel Passing The On-Site Inspection For Drug Registration In China

Zhaoke Ophthalmology’s Phase III Clinical Trial of Levobetaxolol Hydrochloride (HCl) Eye Drops for Glaucoma Meets Primary Endpoint

Podcast Series Episode 3: Zhaoke Ophthalmology 2021 Interim Results

Zhaoke Ophthalmology’s Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease Meets Primary Endpoint